Primordial Genetics closes new financing round and adds private equity investors

By January 1, 2015April 30th, 2021No Comments

Primordial Genetics today announced the first closing of its Series A-2 financing round, including a group of 5 private investors.
The company will use the capital it has raised to support additional R&D activities to develop superior microbial strains for production of high-value proteins including human therapeutic proteins and industrial enzymes.